Evidence map›Paper›PMID 42306019›Full record

ArticleCureus2026

Early Trajectory of Depressive Symptoms in Alcohol Dependence: Insights From a Four-Week Clinical Decision Window.

Dhiraj Raja, Alankrita Singh, Harpreet Singh

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dhiraj RajaPsychiatry, Heritage Institute of Medical Sciences, Varanasi, IND.
Alankrita SinghPsychiatry, Heritage Institute of Medical Sciences, Varanasi, IND.
Harpreet SinghPsychiatry, Maharishi Markandeshwar Medical College and Hospital, Solan, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlcohol dependence and depressive symptoms commonly coexist in clinical practice, complicating management and outcomes. While previous studies have largely focused on prevalence and association, the early course of depressive symptoms after detoxification remains unclear despite its clinical importance.

methodsIn this single-group prospective observational study, we included 150 newly diagnosed male patients admitted to a tertiary care hospital in Northern India. We assessed alcohol use severity using the Alcohol Use Disorders Identification Test (AUDIT) and evaluated depressive symptoms using the Hamilton Depression Rating Scale (HAM-D). We provided all patients with standard inpatient detoxification along with routine supportive care. After four weeks of abstinence and supportive inpatient management, we reassessed depressive symptoms and continued naturalistic follow-up for up to 12 weeks after discharge, depending on when patients returned for follow-up.

resultsAt admission, 74 patients (49.3%) showed clinically significant depressive symptoms. After four weeks, 29 patients (19.3%) continued to show clinically significant depressive symptoms, while 45 patients (60.8% of those initially symptomatic) showed improvement. HAM-D scores decreased significantly over time (mean reduction 3.92 ± 5.12; p < 0.0001). Alcohol severity showed a positive association with depressive symptoms at both baseline and four weeks.

conclusionThese findings suggest that while many patients improve during early abstinence and supportive inpatient management, a substantial proportion continue to experience depressive symptoms. The early postdetoxification period may provide a clinically useful timeframe for reassessment and further management planning.

Indexed as

alcohol dependencealcohol use disorderauditdepressive symptomsdetoxificationham-d

Identifiers

PMID42306019
PMCPMC13266485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.